We are live on ! Find out more
MACM

March Altus Capital Management Portfolio holdings

AUM $16M
1-Year Est. Return 18.92%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+18.92%
3 Year Est. Return
+155.68%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$311M
AUM Growth
-$18.7M
Cap. Flow
-$28.5M
Cap. Flow %
-9.16%
Top 10 Hldgs %
51.43%
Holding
37
New
9
Increased
4
Reduced
13
Closed
9

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$17.1M
2
PODD icon
Insulet
PODD
+$12M
3
BIIB icon
Biogen
BIIB
+$11.7M
4
INCY icon
Incyte
INCY
+$11.3M
5
ZTS icon
Zoetis
ZTS
+$11M

Top Sells

Rank Stock Value
1
AON icon
Aon
AON
+$12.3M
2
BAX icon
Baxter International
BAX
+$12.1M
3
HUM icon
Humana
HUM
+$11.6M
4
EHTH icon
eHealth
EHTH
+$11.3M
5
PRGO icon
Perrigo
PRGO
+$11.2M

Sector Composition

Rank Sector Weight
1 Healthcare 84.92%
2 Materials 5.92%
3 Miscellaneous 4.94%
4 Industrials 4.21%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FURX
26
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$6.09M 1.95%
+69,960
New +$5.4M
IART icon
27
Integra LifeSciences
IART
$1.21B
$5.93M 1.91%
315,698
-309,146
-49% -$5.97M
PGEN icon
28
Precigen
PGEN
$2.45B
$5.86M 1.88%
+233,371
New +$6.46M
AON icon
29
Aon
AON
$64.2B
– –
-146,694
Closed -$12.3M
BAX icon
30
Baxter International
BAX
$12.3B
– –
-321,015
Closed -$12.1M
EHTH icon
31
eHealth
EHTH
$29.9M
– –
-243,399
Closed -$11.3M
HUM icon
32
Humana
HUM
$49.2B
– –
-112,502
Closed -$11.6M
MRSH
33
Marsh
MRSH
$84.4B
– –
-120,350
Closed -$5.82M
PRGO icon
34
Perrigo
PRGO
$1.9B
– –
-72,955
Closed -$11.2M
TMO icon
35
Thermo Fisher Scientific
TMO
$225B
– –
-51,545
Closed -$5.74M
GNMK
36
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-223,818
Closed -$2.98M
MDCO
37
DELISTED
Medicines Co
MDCO
– –
-152,809
Closed -$5.9M
1
2

Similar funds

IC
IKOS CIF Limassol, Cyprus $16.7M AUM 0.4% 1-Year Est. Return
PA
Para Advisors New York $17.5M AUM 3.99% 1-Year Est. Return
GMIM
General Motors Investment Management New York $20.3M AUM 55.51% 1-Year Est. Return
JHWCP
J.H. Whitney Capital Partners New Canaan, Connecticut $11.5M AUM 86.36% 1-Year Est. Return
SMPIAI
Spark Management Partners III (AIV I) Boston, Massachusetts $10.1M AUM 12.29% 1-Year Est. Return
NCMG
NCM Capital Management Group Durham, North Carolina $8.24M AUM 11.99% 1-Year Est. Return
CAD
Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return
GPI
Georgian Partners I Toronto, Ontario, Canada $25.3M AUM 21.88% 1-Year Est. Return

March Altus Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, March Altus Capital Management held 37 positions worth $311M, down 5.7% from $330M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

March Altus Capital Management withdrew a net $28.5M in Q1 2014, closing 9 positions and reducing 13 holdings. Its most notable exit was Aon, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 78% a quarter earlier, followed by Materials and Miscellaneous.

Against the trend, March Altus Capital Management opened a new position in United Therapeutics worth $15.7M.

  • March Altus Capital Management's largest Q1 2014 buy was United Therapeutics: 166,725 shares worth $15.7M.
  • March Altus Capital Management added most to Enzymotec Ltd in Q1 2014, an estimated $3.31M increase.
  • March Altus Capital Management's biggest Q1 2014 reduction was HCA Healthcare, cutting an estimated $8.67M.
  • March Altus Capital Management fully exited Aon in Q1 2014, selling an estimated $12.3M.
  • March Altus Capital Management's ten largest holdings make up 51% of its $311M portfolio in Q1 2014.
  • March Altus Capital Management opened 9 new positions and closed 9 in Q1 2014.
  • March Altus Capital Management's portfolio value fell 5.7% quarter-over-quarter to $311M.

Based on March Altus Capital Management's 13F filing for Q1 2014, filed 15 May 2014.